Unusual fluid retention with imatinib therapy for chronic myeloid leukemia [6]

Leukemia and Lymphoma

Volumn 48, Issue 1, 2007, Pages 195-196

  Ostro, Daniel ^a   Lipton, Jeffrey ^a  

^a PRINCESS MARGARET HOSPITAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

AMILORIDE PLUS HYDROCHLOROTHIAZIDE; FUROSEMIDE; HYDROXYUREA; IMATINIB; SPIRONOLACTONE; ANTINEOPLASTIC AGENT; PIPERAZINE DERIVATIVE; PYRIMIDINE DERIVATIVE;

ADULT; ANKLE EDEMA; ARTHRALGIA; BONE MARROW BIOPSY; BREAST REDUCTION; CASE REPORT; CHRONIC MYELOID LEUKEMIA; DISEASE SEVERITY; DRUG SUBSTITUTION; DRUG WITHDRAWAL; FEMALE; FLUID RETENTION; FLUORESCENCE IN SITU HYBRIDIZATION; HUMAN; LETTER; MASTALGIA; MYALGIA; PERIORBITAL EDEMA; PRIORITY JOURNAL; SIDE EFFECT; CHEMICALLY INDUCED DISORDER; EDEMA; METABOLIC DISORDER;

ADULT; ANTINEOPLASTIC AGENTS; EDEMA; FEMALE; HUMANS; LEUKEMIA, MYELOID, CHRONIC; PIPERAZINES; PYRIMIDINES; WATER-ELECTROLYTE IMBALANCE;

EID: 34247178543     PISSN: 10428194     EISSN: 10292403     Source Type: Journal    
DOI: 10.1080/10428190600923157     Document Type: Letter

References (6)

1. Kantarjian, H., Talpaz, M., O'Brien, S., Garcia-Manero, G., Verstovsek, S. and Giles, F. (2004) High-dose imatinib mesylate therapy in newly diagnosed Philadelphia chromosome - positive chronic phase chronic myeloid leukemia. Blood, 103, pp. 2873-2878.
2. Breccia, M., Carmosino, I., Russo, E., Morano, S. G., Latagliata, R. and Alimena, G. (2005) Early and tardive skin adverse events in chronic myeloid leukaemia patients treated with imatinib. Eur J Haematol, 74, pp. 121-123.
3. Shimazaki, C., Ochiai, N., Uchida, R., Fuchida, S. I., Okano, A. and Ashihara, E. (2003) Intramuscular edema as a complication of treatment with imatinib. Leukemia, 17, pp. 804-805.
4. Gambacorti-Passerini, C., Tornaghi, L., Cavagnini, F., Rossi, P., Pecori-Giraldi, F. and Mariani, L. (2003) Gynaecomastia in men with chronic myeloid leukaemia after imatinib. Lancet, 361, pp. 1954-1956.
5. Heuchel, R., Berg, A., Tallquist, M., Ahlen, K., Reed, R. K. and Rubin, K. (1999) Platelet-derived growth factor beta receptor regulates interstitial fluid homeostasis through phosphatidylinositol-3′ kinase signalling. Proc Natl Acad Sci, 96, pp. 11410-11415.
6. Valeyrie, L., Bastuji-Garin, S., Revuz, J., Bachot, N., Wechsler, J. and Berthaud, P. (2003) Adverse cutaneous reactions to imatinib (STI571) in Philadelphia chromosome-positive leukemias: A prospective study of 54 patients. J Am Acad Dermatol, 48, pp. 201-206.